Hydrodynamic gene delivery of CTRP1 gene generated long-term anti-diabetic effects and beneficial effects in preventing HFD-induced obesity and fatty liver, indicating that CTRP1 has the therapeutic potential in maintaining glucose homeostasis and treating obesity-related metabolic disorders. This evidence concerns the gene C1QTNF1 and obesity due to melanocortin 4 receptor deficiency.